SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Standardizing case definitions for monitoring the safety of maternal vaccines globally: GAIA definitions, a review of progress to date.

Davies, HG; Bowman, C; Watson, G; Dodd, C; Jones, CE; Munoz, FM; Heath, PT; Cutland, CL; Le Doare, K (2023) Standardizing case definitions for monitoring the safety of maternal vaccines globally: GAIA definitions, a review of progress to date. Int J Gynaecol Obstet, 162 (1). pp. 29-38. ISSN 1879-3479 https://doi.org/10.1002/ijgo.14843
SGUL Authors: Davies, Hannah Georgia

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview
[img] Microsoft Word (.docx) (Supplementary Tables) Published Version
Available under License Creative Commons Attribution.

Download (36kB)

Abstract

In 2014, the Global Alignment on Immunization safety Assessment in pregnancy consortium (GAIA) was formed, with the goal of developing a harmonized, globally-concerted approach to actively monitor the safety of vaccines in pregnancy. A total of 26 standardized definitions for the classification of adverse events have been developed. The aim of this review was to identify and describe studies undertaken to assess the performance of these definitions. A literature search was undertaken to identify published studies assessing the performance of the definitions, and reference lists were snowballed. Data were abstracted by two investigators and a narrative review of the results is presented. Four studies that have evaluated 13 GAIA case definitions (50%) were identified. Five case definitions have been assessed in high-income settings only. Recommendations have been made by the investigators to improve the performance of the definitions. These include ensuring consistency across definitions, removal of the potential for ambiguity or variations in interpretation and ensuring that higher-level criteria are acceptable at lower levels of confidence. Future research should prioritize the key case definitions that have not been assessed in low- and middle-income settings, as well as the 13 that have not undergone any validation.

Item Type: Article
Additional Information: © 2023 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: adverse events, maternal vaccination, neonatal infections, pharmacovigilance, pregnancy, vaccine safety, adverse events, maternal vaccination, neonatal infections, pharmacovigilance, pregnancy, vaccine safety, 1114 Paediatrics and Reproductive Medicine, Obstetrics & Reproductive Medicine
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Int J Gynaecol Obstet
ISSN: 1879-3479
Language: eng
Dates:
DateEvent
17 June 2023Published
16 May 2023Published Online
25 April 2023Accepted
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 37194339
Web of Science ID: WOS:000988369900001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115463
Publisher's version: https://doi.org/10.1002/ijgo.14843

Actions (login required)

Edit Item Edit Item